A detailed history of Ever Source Wealth Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 37 shares of SRPT stock, worth $4,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 25 48.0%
Holding current value
$4,533
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$113.33 - $163.85 $1,359 - $1,966
12 Added 48.0%
37 $5,000
Q4 2023

Feb 09, 2024

SELL
$67.31 - $124.76 $134 - $249
-2 Reduced 7.41%
25 $2,000
Q3 2023

Nov 03, 2023

SELL
$102.5 - $123.59 $307 - $370
-3 Reduced 10.0%
27 $3,000
Q2 2023

Aug 04, 2023

BUY
$106.4 - $157.19 $1,383 - $2,043
13 Added 76.47%
30 $3,000
Q4 2021

Feb 07, 2022

BUY
$77.28 - $99.42 $1,313 - $1,690
17 New
17 $2,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.